joins
In the past couple of months, the healthcare and pharmaceutical sectors have undergone significant regulatory and policy shifts, highlighting a sustained focus on transparency, quality assurance, and ...
Published On: 27/03/2020
Practice Area: Capital Markets & International Offerings, Corporate & Commercial
Authors:
Radhika Pandey
As COVID-19 continues on its rampage, the Government of India and other authorities have been continuously initiating measures to contain the pandemic, including a nationwide lockdown. The capital markets regulator continues to address the potential compliance issues and provide assistance to listed entities, their shareholders and other participants affected by COVID-19. INDUSLAW’s Radhika Pandey discusses.
